Surgical site infection
SSI · GI / Surgical
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Infection at an operative site within 30 days (or up to 1 year with an implant), classified as superficial incisional, deep incisional or organ/space. Prevention bundles and early source control reduce morbidity, readmission and mortality.
Red flags
- Systemic sepsis / septic shock
- Spreading erythema with pain out of proportion and crepitus (necrotising infection)
- Wound dehiscence with evisceration
- Deep collection or anastomotic leak
- Failure to respond to initial antibiotics
Assessment
Differential diagnosis
- Superficial incisional SSI
- Deep incisional SSI
- Organ/space SSI (intra-abdominal collection)
- Wound haematoma/seroma
- Cellulitis
- Stitch abscess/reaction
- Necrotising soft tissue infection
Investigations
- Wound inspection and probing for depth/collection
- Wound swab / tissue culture (not superficial swabs of chronic wounds)
- FBC, CRP, U&E, lactate
- Blood cultures if systemic sepsis
- Ultrasound/CT for deep or organ-space collection
- Imaging-guided aspiration for microbiology
Management
- Assess severity: local signs vs systemic sepsis and depth of infection
- Open and drain superficial incisional infections; remove a few sutures and express pus
- Send tissue/pus for culture before or alongside antibiotics
- Start empirical antibiotics only where cellulitis, systemic features or deep infection present
- For deep or organ/space SSI arrange imaging and source control (drainage or reoperation)
- Debride devitalised tissue; consider negative-pressure wound therapy for large wounds
- Resuscitate and manage sepsis per Sepsis Six if septic
- Rationalise antibiotics on culture results and local policy
- Optimise glycaemic control, nutrition and tissue perfusion
- Pack/dress and arrange regular wound reviews and community nursing
- Screen and manage MRSA where relevant
- Audit against prevention bundle and document for surveillance
Drugs & doses
Flucloxacillin 500 mg-1 g PO/IV QDS for Gram-positive skin flora
Co-amoxiclav 1.2 g IV TDS for mixed/intra-abdominal sites
Piperacillin-tazobactam 4.5 g IV TDS for severe/deep abdominal SSI
Vancomycin 15-20 mg/kg IV (MRSA, per levels)
Metronidazole 500 mg IV TDS for anaerobic cover
Disposition
Manage superficial SSIs in primary/community care with surgical review; admit for systemic sepsis, deep/organ-space infection or need for source control. Escalate suspected necrotising infection immediately.
Complications & pitfalls
- Wound dehiscence / incisional hernia
- Intra-abdominal abscess and sepsis
- Necrotising soft tissue infection
- Prolonged hospital stay and readmission
- Chronic wound / sinus
- Mesh/implant infection
Exam pearls
- Not every red wound needs antibiotics — opening and draining a superficial SSI is often sufficient
- Pain out of proportion with crepitus or dishwater fluid signals necrotising infection — emergency debridement
- Prevention bundle (normothermia, glycaemic control, appropriate timed prophylaxis, skin prep) reduces SSI most
- Organ/space SSI often needs radiological or surgical source control, not antibiotics alone
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.